Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C von Kalle

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
International Review of Experimental Pathology|January 1, 1992
Hodgkin's disease: analysis of cell line dataC von Kalle, V Diehl
Current Opinion in Oncology|March 1, 1995
Gene therapy and bone marrow transplantationH P Kiem, C von Kalle, F Schuening, et al.
Current Opinion in Hematology|March 27, 1998
New developments in hematopoietic stem cell expansionC von Kalle, H Glimm, G Schulz, et al.
Seminars in Oncology|December 1, 1990
The cell of origin in Hodgkin's diseaseV Diehl, C von Kalle, C Fonatsch, et al.
Seminars in Hematology|October 28, 2004
Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidableC von Kalle, B Fehse, G Layh-Schmitt, et al.
Annals of Hematology|October 24, 2000
Production of stem-cell transplants according to good manufacturing practiceR Bosse, P Kulmburg, C von Kalle, et al.
Blood|August 15, 1990
L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factorI Katay, U Wirnitzer, H Burrichter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's diseaseU Kapp, J Wolf, C von Kalle, et al.
Der Urologe. Ausg. A|August 15, 2013
[Urology in the concept of comprehensive cancer centers]B Hadaschik, S Pahernik, C Grüllich, et al.
Gene Therapy|November 12, 2010
10-year stability of clinical-grade serum-free γ-retroviral vector-containing mediumF Herbst, C R Ball, O Zavidij, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Review of Experimental Pathology|January 1, 1992
Hodgkin's disease: analysis of cell line dataC von Kalle, V Diehl
Current Opinion in Oncology|March 1, 1995
Gene therapy and bone marrow transplantationH P Kiem, C von Kalle, F Schuening, et al.
Current Opinion in Hematology|March 27, 1998
New developments in hematopoietic stem cell expansionC von Kalle, H Glimm, G Schulz, et al.
Seminars in Oncology|December 1, 1990
The cell of origin in Hodgkin's diseaseV Diehl, C von Kalle, C Fonatsch, et al.
Seminars in Hematology|October 28, 2004
Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidableC von Kalle, B Fehse, G Layh-Schmitt, et al.
Annals of Hematology|October 24, 2000
Production of stem-cell transplants according to good manufacturing practiceR Bosse, P Kulmburg, C von Kalle, et al.
Blood|August 15, 1990
L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factorI Katay, U Wirnitzer, H Burrichter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's diseaseU Kapp, J Wolf, C von Kalle, et al.
Der Urologe. Ausg. A|August 15, 2013
[Urology in the concept of comprehensive cancer centers]B Hadaschik, S Pahernik, C Grüllich, et al.
Gene Therapy|November 12, 2010
10-year stability of clinical-grade serum-free γ-retroviral vector-containing mediumF Herbst, C R Ball, O Zavidij, et al.
Pageof 5